added 563,562 shares (+inf%) to their portfolio in Q3 2025, for an estimated $12,460,355 LOOMIS SAYLES & CO L P added 419,077 shares (+38.4%) to their portfolio in Q3 2025, for an estimated $9,265,792 VANGUARD GROUP INC added 417,790 shares (+642.8%) to their portfolio in Q3 2025, for an estimated $9,237,336 To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard
Semchenko, A.V
Gastrointestinal side effects may temporarily worsen with each dose increase but generally improve within 1-2 weeks as your body adjusts
the threshold of 27 kg/m used in many anti-obesity trials reflects a pharmacotherapy eligibility criterion rather than the standard UK BMI classification
Side effects, even if mild, need to be managed